MK-801 처치와 지구성 훈련이 심근의 혈관생성 반응에 미치는 영향

키워드

참고문헌 (50)

1. Harvey PD, "Cognitive functioning in schizophrenia : a consensus statement on its role in the definition and evaluation of effective treatments for the illness", J Clin Psychiatry, 65(3), pp.361~372 (2004)
2. von Hausswolff-Juhlin Y, "Schizophrenia and physical health problems", Acta Psychiatr Scand Suppl, (438), pp.15~21 (2009)
3. Saha S, "A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?", Arch Gen Psychiatry, 64(10), pp.1123~1131 (2007)
4. Laursen TM, "Life expectancy and cardiovascular mortality in persons with schizophrenia", Curr Opin Psychiatry, 25, pp.83~88 (2012)
5. Brown S, "Causes of the excess mortality of schizophrenia", Br J Psychiatry, 177, pp.212~217 (2000)
6. Olfson M, "Premature mortality among adults with schizophrenia in the United States", JAMA Psychiatry, 72(12), pp.1172~1181 (2015)
7. Goff DC, "A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls", Schizophr Res, 80(1), pp.45~53 (2005)
8. Gale CR, "Mental disorders across the adult life course and future coronary heart disease : evidence for general susceptibility", Circulation, 129(2), pp.186~193 (2014)
9. Hennekens CH, "Schizophrenia and increased risks of cardiovascular disease", Am Heart J, 150(6), pp.1115~1121 (2005)
10. Manu P, "Sudden deaths in psychiatric patients", J Clin Psychiatry, 72(7), pp.936~941 (2011)
11. Gill C, "Losing heart: the role of apoptosis in heart disease--a novel therapeutic target?", FASEB J, 16(2), pp.135~146 (2002)
12. Kaul S, "Myocardial capillaries and coronary flow reserve", J Am Coll Cardiol, 52, pp.1399~1401 (2008)
13. Hein S, "Progression from compensated hypertrophy to failure in the pressure-overloaded human heart : structural deterioration and compensatory mechanisms", Circulation, 107, pp.984~991 (2003)
14. Shiojima I, "Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure", J Clin Invest, 115, pp.2108~2118 (2005)
15. Abraham D, "Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy", Circ Res, 87, pp.644~647 (2000)
16. Fulzele S, "Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects", Schizophr Res, 115(2-3), pp.372~373 (2009)
17. Murphy BP, "Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis", Schizophr Res Treatment, 2014, pp.719395~ (2014)
18. Palomino A, "Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients", Prog Neuropsychopharmacol Biol Psychiatry, 44, pp.29~33 (2013)
19. Bellani M, "Cerebellar and lobar blood flow in schizophrenia : a perfusion weighted imaging study", Psychiatry Res, 193(1), pp.46~52 (2011)
20. Green MF, "Approaching a consensus cognitive battery for clinical trials in schizophrenia:the NIMH-MATRICS conference to select cognitive domains and test criteria", Biol Psychiatry, 56(5), pp.301~307 (2004)
21. Kimhy D, "The impact of aerobic exercise on brain-derived neurotrophic factor and neurocognition in individuals with schizophrenia : a single-blind, randomized clinical trial", Schizophr Bull, 41(4), pp.859~868 (2015)
22. Kimhy D, "Aerobic fitness and body mass index in individuals with schizophrenia : Implications for neurocognition and daily functioning", Psychiatry Res, 220(3), pp.784~791 (2014)
23. Vancampfort D, "Promotion of cardiorespiratory fitness in schizophrenia : a clinical overview and meta-analysis", Acta Psychiatr Scand, 132(2), pp.131~143 (2015)
24. Swain RA, "Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat", Neuroscience, 117(4), pp.1037~1046 (2003)
25. Yoon S, "Preliminary effectiveness and sustainability of group aerobic exercise program in patients with schizophrenia", J Nerv Ment Dis, 204(9), pp.644~650 (2016)
26. Yu J, "MK-801 induces schizophrenic behaviors through downregulating Wnt signaling pathways in male mice", Brain Res, 1385, pp.281~292 (2011)
27. Li F, "Memory and the NMDA receptors", N Engl J Med, 361(3), pp.302~303 (2009)
28. Snyder MA, "NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia", Front Cell Neurosci, 7, pp.31~ (2013)
29. Lim AL, "Consequences of early life MK-801administration : long-term behavioural effects and relevance to schizophrenia research", Behav Brain Res, 227(1), pp.276~286 (2012)
30. Lewis SJ, "Cardiovascular effects of the N-methyl-D-aspartate receptor antagonist MK-801 in conscious rats", Hypertension, 13(6 Pt 2), pp.759~765 (1989)
31. De Rossi P, "A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior", Mol Psychiatry, 21(12), pp.1768~1780 (2016)
32. Li JT, "Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats", Eur J Pharmacol, 652(1-3), pp.65~72 (2011)
33. Lou SJ, "Hippocampal neurogenesis and gene expression depend on exercise intensity in juvenile rats", Brain Res, 1210, pp.48~55 (2008)
34. Carlsson M, "Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson’s disease", Trends Neurosci, 13(7), pp.272~276 (1990)
35. Carlsson A, "Neurotransmitter interactions in schizophrenia-therapeutic implications", Eur Arch Psychiatry Clin Neurosci, 249(4), pp.37~43 (1999)
36. Coyle JT, "Glutamate and schizophrenia: beyond the dopamine hypothesis", Cell Mol Neurobiol, 26(4-6), pp.365~384 (2006)
37. 박준기, "Treadmill exercise enhances NMDA receptor expression in schizophrenia mice", Journal of exercise rehabilitation, 10(1), pp.15~21 (2014), 한국운동재활학회[DOI]
38. Lee BH, "Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders", J Affect Disord, 136(1-2), pp.181~184 (2012)
39. Takebayashi M, "Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders", J Neural Transm(Vienna), 117(9), pp.1119~1122 (2010)
40. Siddiqui NI, "Regular physical exercise : way to healthy life", Mymensingh Med J, 19, pp.154~158 (2010)
41. Firth J, "A systematic review and metaanalysis of exercise interventions in schizophrenia patients", Psychol Med, 45(7), pp.1343~1361 (2015)
42. Rosenbaum S, "Physical activity interventions for people with mental illness : a systematic review and meta-analysis", J Clin Psychiatry, 75(9), pp.964~974 (2014)
43. Wu G, "Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction", Am J Physiol Heart Circ Physiol, 296(2), pp.H389~H395 (2009)
44. Iemitsu M, "Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts", Am J Physiol Heart Circ Physiol, 291(3), pp.H1290~H1298 (2006)
45. Rosano JM, "Targeted delivery of VEGF after a myocardial infarction reduces collagen deposition and improves cardiac function", Cardiovasc Eng Technol, 3, pp.237~247 (2012)
46. Sawano A, "Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans", Blood, 97(3), pp.785~791 (2001)
47. Gale NW, "Growth factors acting via endothelial cellspecific receptor tyrosine kinases : VEGFs, angiopoietins, and ephrins in vascular development", Genes Dev, 13(9), pp.1055~1066 (1999)
48. Jones N, "Tek", Tie2 signaling : new and old partners, 2000, pp.19, 13~17
49. Merenmies J, "Receptor tyrosine kinase signaling in vascular development", Cell Growth Diff, 8, pp.3~10 (1997)
50. Ong T, "Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients", Crit Care Med, 38(9), pp.1845~1851 (2010)

관련 논문AI추천